TriVascular Technologies, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/15 Q3

ended 06/30/15 Q2

ended 03/31/15 Q1

ended 12/31/14 FY 2014

ended 09/30/14 Q3

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Registration withdrawal request

Registration withdrawal request

Ownership Filter

New Enterprise Associates 12, Limited Partnership

Redmile Group, LLC

News Filter

Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger

Reports Third Quarter Financial Results

Reports Preliminary Third Quarter Financial Results

Endologix, Inc. and TriVascular Technologies, Inc. Announce Merger to Create a Leading Cardiovascular Growth Company Focused on the Treatment of Aortic Disorders

Reports Second Quarter Financial Results

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC